Thus, XPC mRNA levels may be considered as a predictive-diagnostic biological marker protecting from skin cancer since its low expression level is linked to an increased susceptibility to cancer in XPC-mutation carriers (Khan et al., 2005). The gene discussed is XPC; the disease is skin neoplasm.